US Faces Measles Resurgence as Doctors Report Infections in Newborn Babies

Health experts warn that declining vaccination rates and continuing outbreaks have created renewed risks for pregnant women and infants, with doctors reporting congenital measles cases after decades.

WASHINGTON, Nov 17: The United States is facing renewed public health concerns following a sharp resurgence of measles infections, with doctors reporting cases of babies being born with the disease for the first time in decades. Falling vaccination rates, growing vaccine hesitancy and continuing outbreaks have raised concerns among medical professionals about the country’s ability to control the highly contagious infection.

The development comes as the United States is expected to lose the measles-elimination status it maintained for 26 years. The Pan American Health Organization (PAHO), the regional office of the World Health Organisation (WHO), has informed the US administration that the country no longer meets the criteria for maintaining its elimination designation, with a formal announcement expected on Tuesday.

According to health officials, approximately 7,700 measles infections and 13 deaths have been reported in the country since 2025. The latest figures represent a significant setback for a nation that had achieved measles elimination in 2000 through widespread vaccination and public health interventions.

Medical specialists are particularly concerned about congenital measles, a condition in which an infected pregnant woman transmits the virus to her unborn child. The infection can cause serious complications in newborns and, in severe cases, may become life-threatening.

Preliminary figures published in a medical alert in NEJM Evidence on Monday indicated that 13 congenital measles cases were reported to the US Centers for Disease Control and Prevention (CDC) between the beginning of 2025 and September 2026.

The same assessment recorded 112 confirmed measles infections among pregnant women during the period. Almost all affected women were either unvaccinated or had an unknown vaccination history.

Public health specialists have described the emergence of congenital measles as a worrying indication of how declining immunisation coverage can create risks for vulnerable populations, including unborn babies and infants who are too young to receive routine vaccinations.

Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, said the development represented a new public health challenge after decades in which measles transmission had been effectively controlled.

Doctors have explained that widespread vaccination had previously reduced the circulation of the virus to such an extent that pregnant women were unlikely to encounter measles. However, declining immunisation rates have allowed infections to spread again, exposing a growing number of susceptible individuals.

The measles, mumps and rubella vaccine, commonly known as MMR, remains the most effective preventive measure. Health professionals recommend that women who are planning pregnancies ensure they have received the recommended vaccination before becoming pregnant.

The vaccine protects women against measles and allows antibodies to pass through the placenta, providing temporary protection to babies during the first months after birth.

However, the MMR vaccine is a live attenuated vaccine and cannot be administered during pregnancy. Women who are unvaccinated and exposed to measles while pregnant may require medical assessment. Certain antibody-based preventive treatments can be given within six days of exposure to reduce the risk of infection and complications.

Doctors have warned that measles infection during the later stages of pregnancy can increase the likelihood of transmission to the newborn. According to guidance from the American Academy of Pediatrics, an estimated 25 to 30 per cent of babies born to women who contract measles shortly before delivery may become infected.

Congenital measles can produce symptoms such as fever, jaundice and the characteristic skin rash associated with the infection. More serious complications include pneumonia and encephalitis, an inflammation of the brain that can cause severe neurological damage.

Another major concern is subacute sclerosing panencephalitis (SSPE), a rare but generally fatal neurological disorder that can develop years after an initial measles infection.

Medical specialists have indicated that children affected by congenital measles may face a heightened risk of developing SSPE, potentially at an earlier stage. Researchers are continuing to examine the long-term consequences of these infections.

The resurgence has also raised questions about the effectiveness of existing vaccination policies and the ability of public health institutions to maintain high immunisation coverage.

According to CDC figures, 92.4 per cent of US kindergarten children received the required MMR vaccinations during the 2025-26 school year. Although the figure remains relatively high, it falls short of the 95 per cent coverage generally recommended by the WHO to prevent sustained community transmission.

The national average also hides considerable differences between communities. Some schools and local areas have reported significantly lower vaccination rates, creating conditions in which the virus can spread rapidly.

During an earlier outbreak in South Carolina, certain schools in Spartanburg County recorded vaccination coverage as low as 20 per cent, illustrating the risks associated with concentrated pockets of unvaccinated populations.

Two doses of the MMR vaccine are approximately 97 per cent effective in preventing measles. Health authorities recommend that communities maintain coverage of at least 95 per cent to provide sufficient protection against outbreaks.

This level of immunisation helps protect not only vaccinated individuals but also people who cannot receive the vaccine for medical reasons, including certain patients with weakened immune systems.

The loss of measles-elimination status is therefore being viewed as an important warning for the American healthcare system.

Under international criteria, a country must demonstrate that it has interrupted sustained transmission of the same measles virus strain for at least 12 months to maintain elimination status. It must also maintain effective disease surveillance and laboratory systems capable of identifying and investigating infections.

The PAHO assessment examined epidemiological and laboratory evidence submitted by the CDC. The outbreak in Utah, which began in June 2025, was identified as a significant factor in the determination because the same virus strain had continued circulating for an extended period.

Measles outbreaks have also been reported in Pennsylvania, New York and Wisconsin, with health specialists expressing concern that not every infection may have been identified or reported.

Public health experts have urged authorities to strengthen vaccination campaigns, improve disease surveillance and expand the capacity of healthcare institutions to investigate suspected cases.

Reuters reported that PAHO had urged the United States to intensify its immunisation efforts to interrupt transmission of the virus and prevent further outbreaks.

Walter Orenstein, professor emeritus at Emory University and a former member of an independent advisory panel involved in reviewing the country’s measles situation, said improving vaccination coverage across communities would be essential to controlling the spread.

The decline in public confidence in vaccines has emerged as another major concern. Experts have linked growing hesitancy to misinformation, changing public health messaging and doubts about vaccine safety that have circulated in recent years.

Josh Michaud, a public health analyst at KFF, said restoring confidence in immunisation would require consistent communication and sustained efforts by healthcare authorities.

Medical professionals have stressed that the MMR vaccine has a well-established safety and effectiveness record. They have urged parents to consult qualified healthcare providers and ensure that children receive recommended doses according to the national immunisation schedule.

The standard childhood schedule generally includes the first MMR dose between 12 and 15 months of age, followed by a second dose between four and six years. During outbreaks, health authorities may recommend earlier vaccination for eligible infants, with the earliest dose generally administered at six months under specific circumstances.

Infants who receive an early dose during an outbreak still require subsequent routine doses to ensure adequate protection.

The renewed spread of measles has also highlighted the importance of protecting pregnant women and newborn babies. Since infants are generally too young for routine vaccination during their first year, their protection depends partly on maternal immunity and high vaccination coverage within the surrounding community.

Healthcare institutions have been advised to remain alert to symptoms among pregnant patients, newborns and individuals with uncertain immunisation histories, particularly in areas experiencing active outbreaks.

Doctors also emphasise the importance of prompt medical attention following suspected exposure. Early assessment can help determine whether preventive treatment, testing or isolation measures are necessary.

The broader challenge for the United States will be rebuilding public trust while improving the ability of healthcare authorities to identify and contain infections.

Experts have warned that regaining elimination status will require more than a temporary decline in reported cases. Authorities must demonstrate that sustained transmission has ended and that effective surveillance systems are in place to detect any new infections.

The latest developments underline how quickly progress against preventable infectious diseases can be reversed when vaccination coverage declines.

Public health specialists believe that stronger immunisation programmes, reliable medical information and coordinated action between healthcare institutions and local communities will be essential to preventing further infections.

The emergence of congenital measles has added urgency to these efforts, demonstrating that declining vaccination rates can have consequences extending beyond individual patients to unborn children and vulnerable newborns.

As the United States confronts the setback, health experts are calling for renewed commitment to routine childhood vaccination and stronger preventive healthcare measures to restore protection against one of the world’s most contagious viral diseases.

United States